Cel Sci Corporation (CVM)

[lightrock]

Not formally no

One way of going about all this suggests it is very very difficult to make it beyond 10% OAS Improvement and therefore very unlikely to be beyond 11.25%

This same way suggests it is very unlikely we made less than 7%

So we can say:
Way #1 = we made 7-11.25%, but the target is 10%

7%---------10%--11.25%

Mid-way (50/50) would be 9%ish. LATELY, FDA seems to like anything >7%

Way 2, more extensive kinds of analysis, we made beyond 20%

How do you combine %'s... :)

Let's just say odds are tilted in our favor.

A lot of people have a lot of money at risk on this, so if I say anything other than 60/40 in favor of success that might be bad for somebody soon.

I think it is 85/15. Having worked so much with the enrollment data and Fosco, etc., but there is something that we do not know and we have no handle to grasp exactly what it is.

@lightrock yes hard to explain less than 20% improvement even harder to reach failure.
Have you got odds of failure?